Mercado de medicina estética en Asia-Pacífico: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de la medicina estética en Asia-Pacífico

El mercado de la estética médica en Asia-Pacífico está fragmentado, ya que está formado por muchos actores de la región, como ALLERGAN, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cynosure, Cutera y Mentor Worldwide LLC, entre otros. La presencia de estas empresas produce precios competitivos para los productos de estética médica en toda la región. Debido a la presencia de estos actores a nivel regional e internacional, los proveedores y fabricantes ofrecen productos con diferentes especificaciones y características para todos los presupuestos. Los avances tecnológicos en aumento están impulsando el crecimiento del mercado. Además, se espera que las iniciativas estratégicas de los actores clave del mercado impulsen el crecimiento del mercado.

Data Bridge Market Research analiza que se espera que el mercado de la medicina estética en Asia-Pacífico alcance un valor de 9.744,43 millones de dólares en 2030, con una tasa de crecimiento anual compuesta (CAGR) del 13,7 % durante el período de pronóstico. Este informe de mercado también cubre en profundidad el análisis de precios y los avances tecnológicos.

Definición de mercado

Aesthetic devices are an innovative advancement, providing a solution to patients with the ingenuity of creating beauty. Medical aesthetics devices are a growing market owing to their benefits such as maintaining a youthful appearance, pain-free and non-invasive beauty treatments, maintenance-free skin that remains smooth and hairless without the need for shaving, waxing, or unpleasant hair treatments, improving the cosmetic appearance, and technological advancement in medical aesthetics devices.

Medical aesthetics devices are a cosmetic treatment that improves appearance by treating conditions such as acne, unwanted hair, wrinkles, sunspots, and others. The benefits are improved appearance, better health, immediate and long-lasting results, increased self-esteem, and others.

Asia-Pacific Medical Aesthetics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Aging Population Asia-Pacific

The sole objective of aesthetic surgery in the aging population is to improve psychological well-being by improving or modifying their body image. The normal body structures are reshaped to accomplish this goal. The aesthetic surgery has successfully improved the quality-of-life-index and reduced depression amongst the elderly population. The growth of the aging population Asia-Pacific has led to the growth of the medical aesthetics market. There has been massive growth in the looks industry in recent years, and the aging population has been one of the drivers in this process. The superficial goal of the perfect body depicted by mass media is a major reason for its growth. People's obsession with looking more youthful leads to various breakthroughs in the aesthetic market.

Technological Advancements

The Asia-Pacific medical aesthetics market is booming because of awareness among prospective customers. The drive to possess the perfect figure and shape humans paces the aesthetics market with innovative technological advancements. The aesthetics market itself has been able to attract a huge number of customers Asia-Pacific. Medical Aesthetics have redefined the definition of perfection. With the increase in technological advancements, there is a reduction in side effects and better quality treatments. This, along with increasing awareness among people, drives the Asia-Pacific medical aesthetics market.

OPPORTUNITY

Imminent Health Revolution

The standard of living in developing countries such as India, Brazil, South Africa, Thailand, and many others has improved in the past decade. People opt for different aesthetic surgeries to maintain themselves, giving them better results without stressful physical efforts. The Asia-Pacific medical aesthetics market remains unexplored in many countries, but the increase in awareness about it amongst emerging countries is leading to its further growth.

RESTRAINT/CHALLENGE

Regulatory scenario

Every medical aesthetics company, no matter how big or small or which market it covers, must adhere to the regulatory requirements. Medical aesthetics is under stringent government regulations. The manufacturers of medical aesthetic devices and products must go through various testing levels before the final validation. Complying with the FDA's standards requires specialized skill sets, resources, time, and money. Medical aesthetics are subjected to pre-market approval application (PMA) per the Federal Food, Drug, and Cosmetic Act (FFDC) and its regulations.

Post-COVID-19 Impact on the Asia-Pacific Medical Aesthetics Market

COVID-19 negatively impacted the Asia-Pacific medical aesthetics market due to the shutdown of Asia-Pacific manufacturing sectors, logistics and transportation, and lack of testing for the product.

The COVID-19 pandemic has impacted the market to an extent negative manner. However, increasing government support and continuous technological advancement are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players and the growing awareness of medical aesthetics products in the region are expected to fuel the market growth further. Also, the growth has been high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple R&D activities to improve the technology involved in the product. With this, the companies will bring advancement and innovation to the market.

Recent Developments

• In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC to improve infraorbital hollows in adults above 21. This helped the company to expand the product portfolio of aesthetics in the U.S. market.
• In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that the FDA had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction. This product has helped the company to expand its product portfolio of aesthetics in the U.S. market.

Asia-Pacific Medical Aesthetics Market Scope

The Asia-Pacific medical aesthetics market is segmented into four notable segments based on product type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

By Product Type

• Aesthetic Laser Devices
• Energy Devices
• Body Contouring Devices
• Facial Aesthetic Devices
• Aesthetic Implants
• Skin Aesthetic Devices

Based on product type, the market is segmented into aesthetic laser devices, energy devices, body contouring devices, facial aesthetic devices, aesthetic implants, and skin aesthetic devices.

By Application

• Anti-Aging and Wrinkles
• Facial and Skin Rejuvenation
• Breast Enhancement
• Body Shaping and Cellulite
• Tattoo Removal
• Vascular Lesions
• Sears, Pigment Lesions Reconstructive
• Psoriasis and Vitiligo
• Others

Based on application, the market is segmented into anti-aging and wrinkles, facial and skin rejuvenation, breast enhancement, body shaping and cellulite, tattoo removal, vascular lesions, sears, pigment lesions, reconstructive, psoriasis and vitiligo and others.

By End User

• Cosmetic Centers
• Dermatology Clinics
• Hospitals
• Medical Spas and Beauty Centers

Based on end user, the market is segmented into cosmetic centers, dermatology clinics, hospitals, medical spas and beauty centers.

By Distribution Channel

• Direct tender
• Retail Sales

Based on distribution channel, the market is segmented into direct tender and retail, sales.

Asia-Pacific Medical Aesthetics Market Regional Analysis/Insights

The Asia-Pacific medical aesthetics market is analyzed, and market size insights and trends are provided by country, product type, application, end user, and distribution channel, as referenced above.

The countries covered in this market report are Japan, India, China, South Korea, Australia, Thailand, Singapore, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.

Japan is expected to dominate the market with the largest market share. This share is attributable to the presence of key market players such as Allergan, Bausch Health Companies Inc., and Lumenis among others. Strategic initiatives by key market players and penetration of new technologies are anticipated to fuel the market growth during the forecast period in the country.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Medical Aesthetics Market Share Analysis

The Asia-Pacific medical aesthetics market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Algunos de los principales actores del mercado que operan en el mercado de estética médica de Asia-Pacífico son Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical（Group）Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Lutronic, Mentor Worldwide LLC, entre otros.

SKU-11704